[Federal Register Volume 80, Number 87 (Wednesday, May 6, 2015)]
[Notices]
[Pages 26051-26053]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-10543]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-15-0978; Docket No. CDC-2015-0030]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on the proposed
information collection for the Emerging Infections Program. The
Emerging Infections Programs (EIPs) are population-based centers of
excellence established through a network of state health departments
collaborating with academic institutions; local health departments;
public health and clinical laboratories; infection control
professionals; and healthcare providers. EIPs assist in local, state,
and national efforts to prevent, control, and monitor the public health
impact of infectious diseases through population-based surveillance.
DATES: Written comments must be received on or before July 6, 2015.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2015-
0030 by any of the following methods:
Federal eRulemaking Portal: Regulation.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact the Information Collection Review Office,
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including
[[Page 26052]]
whether the information shall have practical utility; (b) the accuracy
of the agency's estimate of the burden of the proposed collection of
information; (c) ways to enhance the quality, utility, and clarity of
the information to be collected; (d) ways to minimize the burden of the
collection of information on respondents, including through the use of
automated collection techniques or other forms of information
technology; and (e) estimates of capital or start-up costs and costs of
operation, maintenance, and purchase of services to provide
information. Burden means the total time, effort, or financial
resources expended by persons to generate, maintain, retain, disclose
or provide information to or for a Federal agency. This includes the
time needed to review instructions; to develop, acquire, install and
utilize technology and systems for the purpose of collecting,
validating and verifying information, processing and maintaining
information, and disclosing and providing information; to train
personnel and to be able to respond to a collection of information, to
search data sources, to complete and review the collection of
information; and to transmit or otherwise disclose the information.
Proposed Project
Emerging Infections Program--(OMB Control No. 0920-0978, Expires 8/
31/2016)--Revision--National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Emerging Infections Programs (EIPs) are population-based
centers of excellence established through a network of state health
departments collaborating with academic institutions; local health
departments; public health and clinical laboratories; infection control
professionals; and healthcare providers. EIPs assist in local, state,
and national efforts to prevent, control, and monitor the public health
impact of infectious diseases. Various parts of the EIP have received
separate Office of Management and Budget (OMB) clearances (Active
Bacterial Core Surveillance [ABCs]--OMB number 0920-0802 and All Age
Influenza Hospitalization Surveillance--OMB number 0920-0852); however
this request seeks to have all core EIP activities under one clearance.
Activities of the EIPs fall into the following general categories:
(1) Active surveillance; (2) applied public health epidemiologic and
laboratory activities; (3) implementation and evaluation of pilot
prevention/intervention projects; and (4) flexible response to public
health emergencies.
Activities of the EIPs are designed to: (1) Address issues that the
EIP network is particularly suited to investigate; (2) maintain
sufficient flexibility for emergency response and new problems as they
arise; (3) develop and evaluate public health interventions to inform
public health policy and treatment guidelines; (4) incorporate training
as a key function; and (5) prioritize projects that lead directly to
the prevention of disease.
Proposed respondents will include state health departments who may
collaborate with one or more of the following: Academic institutions,
local health departments, public health and clinical laboratories,
infection control professionals, and healthcare providers. Frequency of
reporting will be determined as cases arise.
The total estimated burden is 22,755 hours. There is no cost to
respondents other than their time.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
State Health Department........................ ABCs Case Report Form.................. 10 809 20/60 2,697
Invasive Methicillin-resistant 10 609 20/60 2,030
Staphylococcus aureus ABCs Case Report
Form.
ABCs Invasive Pneumococcal Disease in 10 22 10/60 37
Children Case Report Form.
ABCs Non-Bacteremic Pneumococcal 10 100 10/60 167
Disease Case Report Form.
Neonatal Infection Expanded Tracking 10 37 20/60 123
Form.
ABCs Legionellosis Case Report Form.... 10 100 20/60 333
Campylobacter.......................... 10 637 20/60 2,123
Cryptosporidium........................ 10 130 10/60 217
Cyclospora............................. 10 3 10/60 5
Listeria monocytogenes................. 10 13 20/60 43
Salmonella............................. 10 827 20/60 2,757
Shiga toxin producing E. coli.......... 10 90 20/60 300
Shigella............................... 10 178 10/60 297
Vibrio................................. 10 20 10/60 33
Yersinia............................... 10 16 10/60 27
Hemolytic Uremic Syndrome.............. 10 10 1 100
Influenza Hospitalization Surveillance 10 400 15/60 1,000
Project Case Report Form.
Influenza Hospitalization Surveillance 10 100 5/60 83
Project Vaccination Telephone Survey.
Influenza Hospitalization Surveillance 10 100 5/60 83v
Project Vaccination Telephone Survey
Consent Form.
EIP site....................................... CDI Case Report Form................... 10 1,650 20/60 5,500
CDI Treatment Form..................... 10 1,650 10/60 2,750
Resistant Gram-Negative Bacilli Case 10 500 20/60 1,667
Report Form.
Person in the community infected with C. Screening Form......................... 600 1 5/60 50
difficile (CDI Cases).
[[Page 26053]]
Telephone interview.................... 500 1 40/60 333
---------------------------------------------------------------
Total...................................... ....................................... .............. .............. .............. 22,728
--------------------------------------------------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-10543 Filed 5-5-15; 8:45 am]
BILLING CODE 4163-18-P